Product NDC: | 52959-527 |
Proprietary Name: | Orphenadrine Citrate |
Non Proprietary Name: | ORPHENADRINE CITRATE |
Active Ingredient(s): | 100 mg/1 & nbsp; ORPHENADRINE CITRATE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52959-527 |
Labeler Name: | H.J. Harkins Company, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040368 |
Marketing Category: | ANDA |
Start Marketing Date: | 20000623 |
Package NDC: | 52959-527-10 |
Package Description: | 10 TABLET, EXTENDED RELEASE in 1 BOTTLE (52959-527-10) |
NDC Code | 52959-527-10 |
Proprietary Name | Orphenadrine Citrate |
Package Description | 10 TABLET, EXTENDED RELEASE in 1 BOTTLE (52959-527-10) |
Product NDC | 52959-527 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ORPHENADRINE CITRATE |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20000623 |
Marketing Category Name | ANDA |
Labeler Name | H.J. Harkins Company, Inc. |
Substance Name | ORPHENADRINE CITRATE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |